Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
Part of paid clinical trials in Jasper, Alabama.
- Sponsor
- Induce Biologics USA Inc.
- Study ID
- NCT06000319
- Status
- Enrolling By Invitation
Conditions
- Degenerative Disc Disease
- Degenerative Spondylolisthesis
- Spinal Stenosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Natural Matrix Protein (NMP) Fibers — BIOLOGICALhuman bone allograft
- Lumbar interbody fusion — PROCEDUREProcedure that involves removing the intervertebral disk from the disk space between between 2 or more vertebrae between L1 and S1. When the disk space has been cleared out, the surgeon fills the void between the vertebrae with a bone void filler.
- Cervical interbody fusion — PROCEDUREProcedure that involves removing the intervertebral disk from the disk space between between 2 or more vertebrae between C2 and T1. When the disk space has been cleared out, the surgeon fills the void between the vertebrae with a bone void filler.
Study Details
The aim of this study is to evaluate the effectiveness and safety of Natural Matrix Protein™ (NMP™) fibers when used in cervical or lumbar interbody fusion in patients with degenerative disc disease (DDD), spinal stenosis, spondylolisthesis undergoing cervical or lumbar interbody spine fusion at no more than 3 adjacent levels.
Key Dates
- Start date
- Jan 4, 2024
- Status verified
- Nov 2025
- Primary completion
- Feb 1, 2027
- Completion
- Aug 1, 2027
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: Lumbar Interbody Fusion with NMPSubject has undergone lumbar interbody spine fusion at no more than 3 adjacent levels between L1 and S1 where NMP fibers have been used as a bone void filler
- Arm: Cervical Interbody Fusion with NMPSubject has undergone cervical interbody spine fusion at no more than 3 adjacent levels between C2 and T1 where NMP fibers have been used as a bone void filler
Primary Outcome Measure
Incidence of interbody fusion [ Time Frame: Baseline to 12 months post-operative ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Alabama Back Institute | Jasper | Alabama | 35501 | - |
Find similar trials in Jasper, AL
By research site
Related Studies
- Assessing Safety of Cervical Spine Fusion With NMP®Not Yet Recruiting · Red Rock Regeneration Inc. · Jasper, Alabama
- A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc DiseasePHASE3 · Recruiting · DiscGenics, Inc. · Birmingham, Alabama
- Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal ConditionsNot Yet Recruiting · R3 Stem Cell · Encino, California
- Advanced Materials Science in XLIF StudyEnrolling By Invitation · NuVasive · Hartford, Connecticut